NuGEN Technologies, Inc. Scientists Screen 400+ Genes For Fusion Events In Single Assay; Detect New Fusions And Those Previously Associated With Cancers

SAN CARLOS, Calif.--(BUSINESS WIRE)--Scientists at NuGEN Technologies, Inc. have simultaneously surveyed RNA of more than 400 targeted genes in a single assay, using next generation sequencing (NGS) to detect fusions known to be key drivers of tumor growth in several cancer types. The scientists, who employed an innovative method of targeted sequence library preparation, also discovered low-frequency fusions that had not previously been reported.

Help employers find you! Check out all the jobs and post your resume.